GLP-1 (7-37)

Short Description:


  • Product Name: GLP-1(7-37)
  • Cas No: 106612-94-6
  • Molecular Formula: C151H228N40O47
  • Molecular Weight: 3355.71 g/mol
  • SEQUENCE: H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg -Gly-OH acetate salt
  • APPEARANCE: White powder
  • APPLICATION: A hormone that promotes catabolism,used for Diabetes II - not yet an approved application
  • PACKAGE: According to customer's requirements
  • Product Detail

    Product Tags

    Keywords

    • Human GLP-1 (7-37)
    • most affordable price
    • CAS# 106612-94-6

    Quick Details

    • ProName: Human GLP-1 (7-37)
    • CasNo:106612-94-6
    • Molecular Formula: C151H228N40O47
    • Appearance: white powder
    • Application: 106612-94-6
    • DeliveryTime: prompt shipment
    • PackAge: according to customer’s requirements
    • Port: Shenzhen
    • ProductionCapacity: 2 Kilogram/Month
    • Purity: 98%
    • Storage: 2~8℃. protected from light
    • Transportation: by air
    • LimitNum: 1 Gram

    Superiority

     

    professional peptide manufacturer in china.
    high quality with gmp grade
    large scale with competitive price
    our products include: generic bulk peptide apis, cosmetic peptide, custom peptides and veterinary peptides.

     

    Details

    Molecular Formula:

    C151H228N40O47

    Relative Molecular Mass:

    3355.71 g/mol

    CAS-Number:

    106612-94-6 (net)

    Long-term Storage:

    -20 ± 5°C

    Synonyms:

    Glucagon-Like Peptide 1 (7-37)

    Sequence:

    H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg

    -Gly-OH acetate salt

    Fields of Application:

    Diabetes II - not yet an approved application

    Active Substance:

    GLP-1 (7-37) is an insulinotropic peptide generated from the precursor peptide GLP-1 (1-37). After ingestion of a meal,

    the truncated bioactive sequences GLP-1 (7-37) and GLP-1 (7-36) amide are secreted by the L cells of the intestinal

    mucosa. Administration of GLP-1 (7-37) acetate augments glucose induced insulin secretion and simultaneously inhibits glucagon

    secretion and gastric emptying.

     

     

    Company Profile:

    company name:Shenzhen JYMed Technology Co.,Ltd.
    Year Established:2009
    Capital: 89.5 Million RMB
    Main product: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,Glucagon Acetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide Aceteate ,Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin
    Acetate, Argireline Acetate, Metrixyl Acetate,Snap-8,…..
    We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis.JYM has successfully submitted a lot
    of ANDA peptide APIs and formulated products with CFDA and have over fourty patents approved.
    Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of  30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.
    With its excellent quality, most competitive price and strong technical support, JYM not only has gained recognitions for its products from Research organizations and Pharmaceutical industries, but also become one of the most reliable suppliers of peptides in China,. JYM is dedicated to be one of the world’s leading peptide provider in the near future.

  • Previous:
  • Next:

  • Write your message here and send it to us